Pharmacogenomics of Stimulant Treatment Response

Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD

NCT02430896 ·Status: UNKNOWN

ERP Based Single-dose Predictions of Stimulants

NCT02695355 ·Status: COMPLETED ·Phase: PHASE2

Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in ADHD

NCT00756158 ·Status: COMPLETED

Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00409708 ·Status: COMPLETED ·Phase: PHASE2

The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder

NCT00773916 ·Status: COMPLETED ·Phase: PHASE4

Stimulant Effects on Brain Activity

NCT02453698 ·Status: COMPLETED ·Phase: PHASE1

A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD

NCT02811211 ·Status: COMPLETED

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

NCT00183391 ·Status: COMPLETED ·Phase: PHASE4

Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD)

NCT00757029 ·Status: COMPLETED ·Phase: PHASE4

To Explore the Influence of Appetite Reduction and Medication Effect of Methylphenidate in Patients With Attention-deficit/Hyperactivity Disorder(ADHD) Through Pharmacogenetics.

NCT04006548 ·Status: COMPLETED

A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations

NCT03233867 ·Status: COMPLETED

Methylphenidate Studies for Drug Abuse Vulnerability Molecular Genentics

NCT00247689 ·Status: TERMINATED

Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder

NCT02951754 ·Status: RECRUITING ·Phase: PHASE4

Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy

NCT01330693 ·Status: UNKNOWN ·Phase: PHASE3

Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301

NCT05286762 ·Status: COMPLETED ·Phase: PHASE3

Biomarkers of ADHD Treatment Response

NCT05650775 ·Status: COMPLETED ·Phase: PHASE1

Genetic Measurements in Blood Cells of Children Taking Adderall or Methylphenidate

NCT00341029 ·Status: COMPLETED

Attention Deficit Hyperactivity Disorder: Nutrition and Environment

NCT02999503 ·Status: UNKNOWN ·Phase: NA

Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD

NCT02167048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

PK/PD Pediatric ADHD Classroom Study

NCT02536105 ·Status: COMPLETED ·Phase: NA

A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors

NCT01624649 ·Status: COMPLETED

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

NCT00301236 ·Status: COMPLETED ·Phase: PHASE3

The Relationship Between CES1 Genotype and Methylphenidate Response in Children With ADHD - INDICES Work Package 6

NCT04366609 ·Status: COMPLETED

Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

NCT05924594 ·Status: SUSPENDED ·Phase: PHASE3

A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)

NCT00475735 ·Status: COMPLETED ·Phase: PHASE2